Novateor Research Laboratories Limited (BOM:542771)
32.85
+0.20 (0.61%)
At close: May 12, 2026
BOM:542771 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 4.68 | 2.66 | 0.89 | 2.19 | 4.75 |
Cash & Short-Term Investments | 4.68 | 2.66 | 0.89 | 2.19 | 4.75 |
Cash Growth | 75.99% | 197.98% | -59.31% | -53.81% | -27.84% |
Accounts Receivable | 28.21 | 20.74 | 11.24 | 7.02 | 4.33 |
Other Receivables | - | 1.15 | 1.78 | 0.54 | - |
Receivables | 28.21 | 21.89 | 13.02 | 7.56 | 4.37 |
Inventory | 10.51 | 7.71 | 6.98 | 5.63 | 4.99 |
Other Current Assets | 66.1 | 59.1 | 54.28 | 49.51 | 46.92 |
Total Current Assets | 109.5 | 91.36 | 75.17 | 64.9 | 61.04 |
Property, Plant & Equipment | 32.39 | 34.06 | 28.7 | 22.15 | 19.45 |
Long-Term Investments | 0.11 | 0.1 | 0.1 | 0.1 | 0.1 |
Long-Term Deferred Charges | - | - | - | - | 0.82 |
Other Long-Term Assets | 0.62 | 0.62 | 0.62 | 2.36 | - |
Total Assets | 142.61 | 126.13 | 104.59 | 89.51 | 81.41 |
Accounts Payable | 14.37 | 9.02 | 5.45 | 1.63 | 0.29 |
Accrued Expenses | - | - | - | - | 0.26 |
Short-Term Debt | 6.98 | 1.4 | 1.77 | 1.75 | - |
Current Portion of Long-Term Debt | - | 0.91 | 1.08 | - | - |
Current Income Taxes Payable | 0.35 | 0.36 | 0.04 | 0.01 | 0.03 |
Other Current Liabilities | 2.17 | 4.63 | 3.64 | 3.91 | -0.06 |
Total Current Liabilities | 23.87 | 16.31 | 11.96 | 7.31 | 0.52 |
Long-Term Debt | 3.24 | 4.09 | 4.71 | 3.3 | 2.37 |
Long-Term Deferred Tax Liabilities | 0.47 | 0.32 | 0.29 | 0.12 | 0.11 |
Total Liabilities | 27.58 | 20.72 | 16.96 | 10.73 | 2.99 |
Common Stock | 60.52 | 48.34 | 48.34 | 48.34 | 48.34 |
Additional Paid-In Capital | - | 27.22 | 27.21 | 27.21 | 27.21 |
Retained Earnings | - | - | - | 0.24 | -0.15 |
Comprehensive Income & Other | 54.51 | 29.86 | 12.07 | 2.99 | 3.02 |
Shareholders' Equity | 115.03 | 105.41 | 87.63 | 78.78 | 78.42 |
Total Liabilities & Equity | 142.61 | 126.13 | 104.59 | 89.51 | 81.41 |
Total Debt | 10.22 | 6.4 | 7.55 | 5.05 | 2.37 |
Net Cash (Debt) | -5.54 | -3.74 | -6.66 | -2.86 | 2.39 |
Net Cash Growth | - | - | - | - | -42.50% |
Net Cash Per Share | -0.93 | -0.62 | -1.10 | -0.59 | 0.49 |
Filing Date Shares Outstanding | 5.95 | 4.83 | 4.83 | 4.83 | 4.83 |
Total Common Shares Outstanding | 5.95 | 4.83 | 4.83 | 4.83 | 4.83 |
Working Capital | 85.64 | 75.05 | 63.21 | 57.59 | 60.53 |
Book Value Per Share | 19.32 | 21.81 | 18.13 | 16.30 | 16.22 |
Tangible Book Value | 115.03 | 105.41 | 87.63 | 78.78 | 78.42 |
Tangible Book Value Per Share | 19.32 | 21.81 | 18.13 | 16.30 | 16.22 |
Land | - | 10 | 10 | 10 | 10 |
Buildings | - | 9.49 | 2.88 | 2.88 | 2.88 |
Machinery | - | 22.43 | 17.65 | 10.39 | 10.27 |
Construction In Progress | - | - | 4.42 | 4.32 | 0.88 |